scholarly journals Postoperative Serum Lactate Levels for In-Hospital Mortality Prediction Among Heart Transplant Recipients

2020 ◽  
Vol 25 ◽  
Author(s):  
Anna Kędziora ◽  
Karol Wierzbicki ◽  
Jacek Piątek ◽  
Hubert Hymczak ◽  
Izabela Górkiewicz-Kot ◽  
...  
PeerJ ◽  
2020 ◽  
Vol 8 ◽  
pp. e8334
Author(s):  
Anna Kędziora ◽  
Karol Wierzbicki ◽  
Jacek Piątek ◽  
Hubert Hymczak ◽  
Izabela Górkiewicz-Kot ◽  
...  

Background Advanced heart failure (HF), that affects 10% of the HF population, is associated with high mortality rate, meeting 50% at 1-year from diagnosis. For these individuals, heart transplantation (HTX) remains the ultimate and the gold-standard treatment option. Serum lactate level measurements has been proven useful for determining the outcome following other cardiac surgeries and among critically ill patients. Increased serum lactate levels are expected following HTX; however, no detailed analysis has been yet performed in this population. The research aims to estimate the prevalence of hyperlactatemia and describe early postoperative serum lactate level trends among heart transplant recipients. Materials and Methods Forty-six consecutive patients, who underwent HTX between 2010 and 2015, were enrolled into the retrospective analysis. Serum lactate level measurements within first 48 hours post-HTX were obtained every 6 hours from routinely conducted arterial blood gas analyses. The threshold for hyperlactatemia was considered at >1.6 mmol/L, according to upper limit of normal, based on internal laboratory standardization. The highest observed measurement within the observation, regardless of the time point of observation was determined for each patient individually and was appointed as Peak Value. Results Consecutively measured serum lactate levels differed in time (p = 0.000), with the initial increase and subsequent decrease of the values (4.3 vs. 1.9 mmol/l; p = 0.000). The increase from the baseline level to the Peak Value was statistically significant (4.3 vs. 7.0 mmol/l; p = 0.000). Various serum lactate level trends were identified, with one or more hyperlactatemia episodes. Eventually, 50% of the individuals had normal serum lactate levels at the end of the study, and hyperlactatemia was observed in the other half. Conclusions Throughout the observation, all of the patients experienced at least one episode of hyperlactatemia, with the median Peak Value of 7.0 (4.5–8.4) mmol/L. Various serum lactate level trends can be identified in post-HTX patients. Further research is required to determine the clinical usefulness of newly reported serum lactate level trends among heart transplant recipients.


2014 ◽  
Vol 148 (1) ◽  
pp. 282-289 ◽  
Author(s):  
Rachel D. Vanderlaan ◽  
Cedric Manlhiot ◽  
Jennifer Conway ◽  
Osami Honjo ◽  
Brian W. McCrindle ◽  
...  

2021 ◽  
Vol 9 ◽  
pp. 205031212199329
Author(s):  
Sakiru Oyetunji Isa ◽  
Olajide Buhari ◽  
Muminat Adeniran-Isa ◽  
Mahin Khan ◽  
Hafiz Khan ◽  
...  

Introduction: The average age and survival of heart transplant recipients have improved significantly over the last 10 years. In these long-term survivors, coronary allograft vasculopathy is one of the most common causes of death. There is a paucity of large-data research highlighting the short-term outcomes of percutaneous coronary interventions in cardiac allograft recipients. Methods: We compared the in-hospital outcomes of heart transplant recipient and non-transplant recipients following percutaneous coronary intervention using data from the National inpatient sample (NIS). All adult patients (age ⩾ 18 years) who had percutaneous coronary intervention in the index admissions from January of 2005 to December of 2014 were included in the analysis. They were then divided into two groups based on their heart transplant status. The primary outcome was in-hospital mortality. Secondary outcomes were stroke, cardiac arrest, duration of hospitalization, and total hospital charges. Logistic regression models were used to compare in-hospital outcomes between the two groups. Results: Of 1,316,528 patients who had percutaneous coronary intervention, 618 (0.05%) were heart transplant recipients and 1,315,910 (99.95%) were not. The heart transplant recipient group was significantly younger with lower rates of obesity and peripheral vascular disease but higher rate of chronic kidney disease, iron deficiency anemia, and chronic liver disease. There was significantly higher in-hospital mortality in transplant recipients below 65 years of age (adjusted odds ration = 2.3, p value < 0.0001). Subjects in the heart transplant recipient group also had longer hospital stays ( p value = 0.002). Conclusion: Heart transplant recipients younger than 65 years had higher in-hospital mortality. Subjects in the heart transplant recipient group were also younger and had longer duration of hospitalization than the non-transplant cohorts.


2006 ◽  
Vol 5 (1) ◽  
pp. 40-40
Author(s):  
R BESTETTI ◽  
T THEODOROPOULOS ◽  
T SOUZA ◽  
M LIMA ◽  
E BURDMANN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document